Opening on a gloomy tone today, the Indian stock market saw falls in both the Sensex and the Nifty under conflicting global signals. As of February 20, 2025 the Sensex is trading at 75,638.77 (-0.40%), whereas the Nifty 50 comes at 22,865.30 (-0.29%). Reflecting this negative market attitude, the Nifty Bank index likewise dropped 0.60%.
Top Losers and Gainers
Most gains:
- Shriram Finance: RS 568.65 +/- 1.95%.
- Hindalco: Positive movement with high purchase activity
- Among the main profiteers in today’s trading are SBI Life Insurance, Cipla, Adani Ports.
Highest Losers:
- Maruti Suzuki: -1.64% – Rs 12,478.60
- M&M, ITC, Sun Pharma, Wipro: notable falls influencing the indexes
- Sectorial Performance
Although other sectoral indexes were trading in the negative, Nifty Metal came out as the best-performing sector with a 0.62% gain, suggesting ongoing strength in commodities stocks. Conversely, Nifty FMCG performed the poorest, down 0.78%, therefore driving the market down.
Development Specific to Stocks
Just Dial Share Price Rally: The stock touched a 52-week high of Rs 1,394.95 and a low of Rs 755.30 after extending its advances for the third running. It trades at 19.81% above its low and 35.13% below its peak.
Avantel Gets Rs 43.25 Cr Purchase order for delivery, installation, and commissioning of equipment for Xponders came from NewSpace India.
at just thirty days, Dhani Services sold 195 units at Indiabulls Estate & Club valued more than Rs 1,000 crore. This massive deal emphasises the demand in the real estate market.
Insights of the Market Expert
Axis Securities Head of Research, Akshay Chinchalkar:
“The Nifty closed somewhat lower, but solid demand close to the 22,700 – 22,800 zone points to market resilience. For a definite trend direction, the indices must venture outside the 22,700 – 23,300 area.
Head Investment Strategist Geojit Financial Services, V K Vijayakumar:
“Indian pharma equities have been much changed by Trump’s tariff declaration on semiconductors, cars, and drugs. Should this be done, US market shortages and price spikes might follow. Positively, RBI’s showing of recovery from growth points for H2 FY25 signals favourably for profits increase in FY26.
Global Market Significance:
Recent remarks by Trump on imposing a 25% tax on crucial industries have spooked international markets, especially affecting Indian pharmaceutical exports. RBI’s positive view of economic recovery also gives confidence for stable markets in the next months.
Future Market Analysis
- Advice from professionals advise monitoring:
- Nifty’s motion inside the 22,700–23,300 range
- Performance of the pharmaceutical industry considering US tariff issues
- Midcap and small-cap buying patterns as search for underpriced prospects
Finally
Although the markets began on a less impressive basis, several equities like Hindalco and Shriram Finance have showed resilience. Investors should be aware of new developments as macro variables, global signals, and business profits are so important. Continue following live updates to have further understanding of the path of the stock market. source moneycontrol
For more such interesting and updated news or articles, Subscribe to apexadpros.
